|
H6: code c19 - a review of the manufacturing records indicated the lot met all pre-release specifications.H6: code b20 -the device remains implanted and was therefore not available for engineering evaluation by gore.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu) state ¿adverse events that may occur and/or require intervention include, but are not limited to endoprosthesis or delivery system: component migration, endoleaks and aneurysm enlargement.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
The following was reported to gore: on (b)(6)2013, patient underwent an unknown endovascular procedure utilizing a gore® excluder® aaa endoprosthesis.On (b)(6) 2024, patient was seen on a follow-up for a para visceral aortic aneurysm with growth to 5.65cm.On (b)(6) 2025, the patient was brought in for a reintervention for proximal neck degeneration of the trunk ipsilateral leg and device migration (distance unknown) along with type 1 proximal endoleak.It was previously thought the implanted grafts were non-gore stents (medtronic).It was only during intra-operative that it was discovered implanted grafts were gore grafts.Physician treated by converting to a 5-vessel physician-modified endografts (pmeg) to realign the original implanted graft.The endoleak was resolved and patient tolerated the procedure.
|